MindWalk Holdings Corp. (HYFT)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20262 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to MindWalk Holdings Corp.’s names, not what it holds today.
0 published
1 published
Names not counted (5)
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jul 16, 2024 | 12,037,383 | Anti-spike glycoprotein antibodies and the therapeutic use thereof | Pharmaceuticals | Talem Therapeutics LLC |
| Apr 11, 2023 | 11,623,949 | Anti-spike glycoprotein antibodies and the therapeutic use thereof | Pharmaceuticals | Talem Therapeutics LLC |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 23, 2022 | 2022/0199200 | BIOLOGICAL SEQUENCING | Computer technology | BIOCLUE BV |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.